CEL-SCI Corporation has entered into an Underwriting Agreement with ThinkEquity, LLC to issue and sell 2,500,000 shares of common stock at a price of $2.00 per share, expecting to receive approximately $4,500,000 in net proceeds from the offering. The proceeds will be used to fund the continued development of Multikine and for general corporate purposes.